Cargando…
Antiproteases as Therapeutics to Target Inflammation in Cystic Fibrosis
Cystic Fibrosis (CF) is the most common fatal inherited disease of Caucasians, affecting about 1 in 3000 births. Patients with CF have a recessive mutation in the gene encoding the CF transmembrane conductance regulator (CFTR). CFTR is expressed in the epithelium of many organs throughout the exocri...
Autores principales: | Quinn, Derek J, Weldon, Sinéad, Taggart, Clifford C |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Bentham Open
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2864511/ https://www.ncbi.nlm.nih.gov/pubmed/20448835 http://dx.doi.org/10.2174/1874306401004010020 |
Ejemplares similares
-
The Role of Serine Proteases and Antiproteases in the Cystic Fibrosis Lung
por: Twigg, Matthew S., et al.
Publicado: (2015) -
The Ability of Secretory Leukocyte Protease Inhibitor to Inhibit Apoptosis in Monocytes Is Independent of Its Antiprotease Activity
por: McGarry, Niamh, et al.
Publicado: (2015) -
The Effect of CFTR Modulators on Airway Infection in Cystic Fibrosis
por: Harvey, Caitlyn, et al.
Publicado: (2022) -
Changes of Proteases, Antiproteases, and Pathogens in Cystic Fibrosis Patients' Upper and Lower Airways after IV-Antibiotic Therapy
por: Müller, Ulrike, et al.
Publicado: (2015) -
Protease–Antiprotease Imbalance in Bronchiectasis
por: Oriano, Martina, et al.
Publicado: (2021)